Published in Can J Gastroenterol on March 01, 2013
Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies. PLoS One (2016) 1.52
Time-trends in the prescribing of gastroprotective agents to primary care patients initiating low-dose aspirin or non-steroidal anti-inflammatory drugs: a population-based cohort study. Br J Clin Pharmacol (2015) 0.77
Critical views in gastroenterology & hepatology: aspirin prophylaxis: putting gut bleeds into perspective. Gastroenterol Hepatol (N Y) (2014) 0.77
Comparison of Estimates between Cohort and Case-Control Studies in Meta-Analyses of Therapeutic Interventions: A Meta-Epidemiological Study. PLoS One (2016) 0.75
Venous thromboprophylaxis in gastrointestinal bleeding. Can J Gastroenterol Hepatol (2015) 0.75
Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk. Cardiovasc Ther (2016) 0.75
Risk of bleeding after hospitalization for a serious coronary event: a retrospective cohort study with nested case-control analyses. BMC Cardiovasc Disord (2016) 0.75
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med (1989) 13.83
Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.89
Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) (1988) 6.76
Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA (2008) 6.15
European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci (1996) 6.12
Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 5.65
Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ (1995) 4.50
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet (2000) 4.38
Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet (1996) 4.21
Non-steroidal anti-inflammatory drugs and peptic ulcers. BMJ (1990) 4.10
Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med (2009) 3.90
Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol (2006) 3.67
Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. N Engl J Med (1974) 3.57
Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. Am J Cardiol (2005) 3.05
Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ (2000) 3.02
The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry (1991) 2.49
The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. Br J Clin Pharmacol (1993) 2.39
Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol (2000) 2.18
Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin. Am J Gastroenterol (2008) 1.99
Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study. Neurology (2011) 1.97
Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med (2000) 1.96
Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med (2006) 1.76
The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol (1999) 1.73
Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies. Br J Clin Pharmacol (2001) 1.63
Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Saf (2004) 1.56
Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users. Aliment Pharmacol Ther (1999) 1.56
Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment. Curr Med Res Opin (2007) 1.44
Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther (1993) 1.38
Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med (2002) 1.35
Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding. Aliment Pharmacol Ther (2002) 1.35
Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur J Clin Pharmacol (2006) 1.33
The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 1.32
Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations. BMC Clin Pharmacol (2001) 1.30
Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other nonnarcotic analgesics. Arch Intern Med (1988) 1.20
Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis. Clin Gastroenterol Hepatol (2011) 1.18
Adverse effects of low-dose aspirin in a healthy elderly population. Clin Pharmacol Ther (1993) 1.12
Upper gastrointestinal bleeding associated with antiplatelet drugs. Aliment Pharmacol Ther (2006) 1.04
Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes. Front Pharmacol (2010) 0.91
Analysis of the risk factors and their combinations in acute gastroduodenal ulcer bleeding: a case-control study. Scand J Gastroenterol (2007) 0.86
Aspirin in cardiology--benefits and risks. Int J Clin Pract (2009) 0.85
Efficacy and safety of different aspirin dosages on vascular diseases in high-risk patients. A metaregression analysis. Online J Curr Clin Trials (1995) 0.84
Aspirin: benefit and risk in thromboprophylaxis. QJM (1998) 0.81
Effects of nitrate and prophylactic aspirin on upper gastrointestinal bleeding: a retrospective case-control study. J Int Med Res (1998) 0.81
Unstable angina: status of aspirin and other forms of therapy. Circulation (1985) 0.78
Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events. A critical analysis. J Clin Gastroenterol (1995) 0.77
Risk factors involved in patients with bleeding peptic ulcers: a case-control study. Dig Dis Sci (2008) 0.76
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet (2005) 17.75
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (2012) 12.62
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust (2006) 11.40
Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72
Single, rapid coastal settlement of Asia revealed by analysis of complete mitochondrial genomes. Science (2005) 6.86
International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med (2010) 6.36
Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA (2004) 6.06
Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol (2011) 5.72
Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol (2006) 5.39
Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med (2003) 4.98
New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis. Gastroenterology (2013) 4.58
Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med (2009) 4.11
Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2009) 3.66
Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J (2004) 3.52
The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol (2009) 3.44
Corticosteroids and the risk of atrial fibrillation. Arch Intern Med (2006) 3.28
The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol (2011) 3.26
Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology (2008) 3.18
Competence measurement during colonoscopy training: the use of self-assessment of performance measures. Am J Gastroenterol (2012) 3.17
Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA (2013) 3.15
Canadian Association of Gastroenterology consensus guidelines on safety and quality indicators in endoscopy. Can J Gastroenterol (2012) 3.15
Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology (2005) 3.10
Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. Gastroenterology (2011) 3.08
Electronic alerts versus on-demand decision support to improve dyslipidemia treatment: a cluster randomized controlled trial. Circulation (2008) 2.81
Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J (2005) 2.72
Unlicensed and off label prescription of drugs to children: population based cohort study. BMJ (2002) 2.34
Incidence rates and treatment of neuropathic pain conditions in the general population. Pain (2008) 2.30
Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD. Eur Respir J (2013) 2.27
High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study. Br J Gen Pract (2014) 2.27
Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol (2007) 2.26
Double balloon enteroscopy and capsule endoscopy for obscure gastrointestinal bleeding: an updated meta-analysis. J Gastroenterol Hepatol (2011) 2.24
Chronic gastrointestinal ischaemia: shifting paradigms. Gut (2010) 2.23
Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Gastrointest Endosc (2006) 2.10
Quality evaluation of colonoscopy reporting and colonoscopy performance in daily clinical practice. Gastrointest Endosc (2011) 2.09
Association between calcium channel blockers and gingival hyperplasia. J Clin Periodontol (2010) 2.07
High cancer risk and increased mortality in patients with Peutz-Jeghers syndrome. Gut (2011) 2.06
Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet (2004) 2.06
Increased risk of achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med (2003) 2.02
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf (2013) 2.01
Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands. Drug Saf (2006) 2.01
A case series of proton pump inhibitor-induced hypomagnesemia. Am J Kidney Dis (2010) 1.99
Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study. Neurology (2011) 1.97
[Drugs and cancer risk: the example of THM]. Rev Prat (2013) 1.97
Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation. Inflamm Bowel Dis (2011) 1.97
Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc (2009) 1.97
Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus. Clin Gastroenterol Hepatol (2012) 1.96
Cure of Barrett's carcinoma by ifosfamide chemotherapy. Eur J Gastroenterol Hepatol (2002) 1.92
Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case-control study. Ann Intern Med (2010) 1.91
Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst (2009) 1.89
Differences in proximal serrated polyp detection among endoscopists are associated with variability in withdrawal time. Gastrointest Endosc (2013) 1.87
Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet (2010) 1.86
Transcriptional profiling of Helicobacter pylori Fur- and iron-regulated gene expression. Microbiology (2005) 1.85
Using electronic health care records for drug safety signal detection: a comparative evaluation of statistical methods. Med Care (2012) 1.82
Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Digestion (2011) 1.80
Antipsychotics and the risk of sudden cardiac death. Arch Intern Med (2004) 1.78
A systematic review of patient inflammatory bowel disease information resources on the World Wide Web. Am J Gastroenterol (2007) 1.77
Electrocautery therapy for refractory anastomotic strictures of the esophagus. Gastrointest Endosc (2006) 1.76
Climate change and postglacial human dispersals in southeast Asia. Mol Biol Evol (2008) 1.74
Single-balloon-assisted colonoscopy in patients with previously failed colonoscopy. Gastrointest Endosc (2010) 1.74
The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study. Am J Gastroenterol (2010) 1.73
Mefloquine increases the risk of serious psychiatric events during travel abroad: a nationwide case-control study in the Netherlands. J Clin Psychiatry (2005) 1.72
Estimates of the cancer burden in Europe from radioactive fallout from the Chernobyl accident. Int J Cancer (2006) 1.71
Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage. Ann Surg (2010) 1.70
ERCP as an outpatient treatment: a review. Gastrointest Endosc (2008) 1.68
Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study. Gut (2010) 1.68
Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial. Am J Gastroenterol (2011) 1.66
Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol (2006) 1.66
Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands. Drug Saf (2010) 1.66
A randomized comparison of electrocautery incision with Savary bougienage for relief of anastomotic gastroesophageal strictures. Gastrointest Endosc (2009) 1.66
Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut (2009) 1.65
Ancient voyaging and Polynesian origins. Am J Hum Genet (2011) 1.65
Challenges in the management of acute peptic ulcer bleeding. Lancet (2013) 1.65
Suppression of p21Rac signaling and increased innate immunity mediate remission in Crohn's disease. Sci Transl Med (2014) 1.64
Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial. Gastrointest Endosc (2004) 1.64
Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening. Value Health (2009) 1.61
Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis (2006) 1.60
Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study. Am J Gastroenterol (2009) 1.60
A nationwide study of three invasive treatments for trigeminal neuralgia. Pain (2011) 1.60
Comparing the diagnostic yields of technologists and radiologists in an invitational colorectal cancer screening program performed with CT colonography. Radiology (2012) 1.60
The Global Rating Scale in clinical practice: a comprehensive quality assurance programme for endoscopy departments. Dig Liver Dis (2012) 1.59
Accuracy of narrow-band imaging in predicting colonoscopy surveillance intervals and histology of distal diminutive polyps: results from a multicenter, prospective trial. Gastrointest Endosc (2013) 1.58
Alcohol-attributable mortality in France. Eur J Public Health (2013) 1.57
Ingestion of acid and alkaline agents: outcome and prognostic value of early upper endoscopy. Gastrointest Endosc (2004) 1.57
Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer. J Clin Oncol (2006) 1.56
Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study. Gastrointest Endosc (2008) 1.56
The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice. Gastrointest Endosc (2009) 1.56
Marketing in the lay media and prescriptions of terbinafine in primary care: Dutch cohort study. BMJ (2004) 1.55
No increased risk of non-Hodgkin's lymphoma with steroids, estrogens and psychotropics (Netherlands). Cancer Causes Control (2003) 1.55
Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. J Clin Oncol (2003) 1.55
Adenoma detection with cap-assisted colonoscopy versus regular colonoscopy: a randomised controlled trial. Gut (2011) 1.53
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet (2012) 1.52
Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus. Am J Gastroenterol (2008) 1.51